Christopher K. H. Tseng

1.2k total citations
14 papers, 967 citations indexed

About

Christopher K. H. Tseng is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Christopher K. H. Tseng has authored 14 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Christopher K. H. Tseng's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). Christopher K. H. Tseng is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). Christopher K. H. Tseng collaborates with scholars based in United States, Malaysia and Ukraine. Christopher K. H. Tseng's co-authors include Víctor E. Márquez, John S. Driscoll, Robert W. Sidwell, John D. Morrey, Donald F. Smee, James A. Kelley, David R. Haines, Jeri S. Roth, Samuel Broder and Hiroaki Mitsuya and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Christopher K. H. Tseng

14 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher K. H. Tseng United States 13 547 407 252 230 153 14 967
Phillip M. Tharnish United States 17 460 0.8× 721 1.8× 373 1.5× 404 1.8× 145 0.9× 30 1.3k
Hubert Hřebabecký Czechia 18 656 1.2× 472 1.2× 466 1.8× 223 1.0× 100 0.7× 104 1.2k
Natalia Dyatkina Russia 17 525 1.0× 386 0.9× 225 0.9× 235 1.0× 70 0.5× 41 959
Tamara R. McBrayer United States 20 485 0.9× 809 2.0× 353 1.4× 442 1.9× 126 0.8× 47 1.3k
Mao‐Chin Liu United States 14 380 0.7× 350 0.9× 288 1.1× 183 0.8× 140 0.9× 33 743
Tony Whitaker United States 17 324 0.6× 555 1.4× 192 0.8× 410 1.8× 83 0.5× 36 1.0k
Mirko Brunetti Italy 16 874 1.6× 222 0.5× 240 1.0× 303 1.3× 42 0.3× 20 1.5k
Junxing Shi United States 16 257 0.5× 450 1.1× 202 0.8× 244 1.1× 155 1.0× 39 864
Priscilla P. Saunders United States 17 768 1.4× 218 0.5× 121 0.5× 154 0.7× 32 0.2× 38 1.1k
Joel V. Tuttle United States 18 889 1.6× 327 0.8× 154 0.6× 445 1.9× 52 0.3× 22 1.3k

Countries citing papers authored by Christopher K. H. Tseng

Since Specialization
Citations

This map shows the geographic impact of Christopher K. H. Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher K. H. Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher K. H. Tseng more than expected).

Fields of papers citing papers by Christopher K. H. Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher K. H. Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher K. H. Tseng. The network helps show where Christopher K. H. Tseng may publish in the future.

Co-authorship network of co-authors of Christopher K. H. Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher K. H. Tseng. A scholar is included among the top collaborators of Christopher K. H. Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher K. H. Tseng. Christopher K. H. Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Greenstone, Heather L., et al.. (2007). NIAID resources for developing new therapies for severe viral infections. Antiviral Research. 78(1). 51–59. 8 indexed citations
2.
Morrey, John D., Donald F. Smee, Robert W. Sidwell, & Christopher K. H. Tseng. (2002). Identification of active antiviral compounds against a New York isolate of West Nile virus. Antiviral Research. 55(1). 107–116. 148 indexed citations
3.
Xu, Ze‐Qi, Earl R. Kern, Louise Westbrook, et al.. (2000). Plant-Derived and Semi-Synthetic Calanolide Compounds within VitroActivity against Both Human Immunodeficiency Virus Type 1 and Human Cytomegalovirus. Antiviral chemistry & chemotherapy. 11(1). 23–29. 12 indexed citations
4.
Tseng, Christopher K. H., Víctor E. Márquez, G. W. A. Milne, et al.. (1991). A ring-enlarged oxetanocin A analog as an inhibitor HIV infectivity. Journal of Medicinal Chemistry. 34(1). 343–349. 50 indexed citations
5.
Márquez, Víctor E., Christopher K. H. Tseng, Hiroaki Mitsuya, et al.. (1990). Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV. Journal of Medicinal Chemistry. 33(3). 978–985. 183 indexed citations
6.
Tseng, Christopher K. H., Víctor E. Márquez, Richard W. Fuller, et al.. (1989). Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. Journal of Medicinal Chemistry. 32(7). 1442–1446. 88 indexed citations
7.
Márquez, Víctor E., et al.. (1988). Total synthesis of (-)-neplanocin A. The Journal of Organic Chemistry. 53(24). 5709–5714. 68 indexed citations
8.
Haines, David R., Christopher K. H. Tseng, & Víctor E. Márquez. (1987). Synthesis and biological activity of unsaturated carboacyclic purine nucleoside analogs. Journal of Medicinal Chemistry. 30(5). 943–947. 39 indexed citations
9.
Márquez, Víctor E., et al.. (1987). Synthesis of 2′,3′-Dideoxycyclopentenyl Carbocyclic Nucleosides as Potential Drugs for the Treatment of AIDS. Nucleosides and Nucleotides. 6(1-2). 239–244. 19 indexed citations
10.
Márquez, Víctor E., Christopher K. H. Tseng, James A. Kelley, et al.. (1987). 2',3'-Dideoxy-2'-fluoro-ara-a. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV). Biochemical Pharmacology. 36(17). 2719–2722. 96 indexed citations
11.
Márquez, Víctor E., Christopher K. H. Tseng, Gulilat Gebeyehu, et al.. (1986). Thiazole-4-carboxamide adenine dinucleotide (TAD). Analogs stable to phosphodiesterase hydrolysis. Journal of Medicinal Chemistry. 29(9). 1726–1731. 41 indexed citations
12.
Glazer, Robert I., M C Knode, Christopher K. H. Tseng, David R. Haines, & Víctor E. Márquez. (1986). 3-deazaneplanocin A: A new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells. Biochemical Pharmacology. 35(24). 4523–4527. 61 indexed citations
13.
Glazer, Robert I., et al.. (1986). 3-Deazaneplanocin: A new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60. Biochemical and Biophysical Research Communications. 135(2). 688–694. 130 indexed citations
14.
Tseng, Christopher K. H. & Víctor E. Márquez. (1985). An improved method of synthesis of neplanocin and related cyclopentenyl-containing nucleosides. Tetrahedron Letters. 26(31). 3669–3672. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phillip M. Tharnish Breakdown of academic impact, for papers by Hubert Hřebabecký Breakdown of academic impact, for papers by Natalia Dyatkina Breakdown of academic impact, for papers by Tamara R. McBrayer Breakdown of academic impact, for papers by Mao‐Chin Liu Breakdown of academic impact, for papers by Tony Whitaker Breakdown of academic impact, for papers by Mirko Brunetti Breakdown of academic impact, for papers by Junxing Shi Breakdown of academic impact, for papers by Priscilla P. Saunders Breakdown of academic impact, for papers by Joel V. Tuttle
Rankless by CCL
2026